Investor Alert

New York Markets Close in:

Denali Therapeutics Inc.



Market open

 --Real time quotes

Jan 26, 2022, 10:01 a.m.





+0.83 +2.46%


Volume 13,106

Real time quotes


Previous close

$ 33.73

$ 34.56


+0.83 +2.46%

Day low

Day high




52 week low

52 week high




Annual Financials for Denali Therapeutics Inc.


Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Cash & Short Term Investments 178.33M406.23M464.3M415.36M1.47B
Cash Only 39.85M218.38M77.12M79.45M507.14M
Short-Term Investments 138.48M187.85M387.17M335.91M962.55M
Total Accounts Receivable 438,000464,0008.55M--
Accounts Receivables, Net --7.36M--
Accounts Receivables, Gross --7.36M--
Bad Debt/Doubtful Accounts -----
Other Receivables --1.18M--
Inventories -----
Finished Goods -----
Work in Progress -----
Raw Materials -----
Progress Payments & Other -----
Other Current Assets 3.19M2.92M7.99M14.68M25.96M
Miscellaneous Current Assets 556,0001.04M1.35M14.68M25.96M
Total Current Assets 181.96M409.61M480.84M430.03M1.5B
20162017201820192020 5-year trend
Net Property, Plant & Equipment 15.26M14.92M25.16M80.66M73.46M
Property, Plant & Equipment - Gross 16.85M19.59M37.17M92.93M94.27M
Buildings -----
Land & Improvements -----
Computer Software and Equipment 373,000439,000458,0001.16M1.25M
Other Property, Plant & Equipment 7.61M7.8M22.36M36M36.18M
Accumulated Depreciation 1.59M4.67M12.01M12.27M20.8M
Total Investments and Advances 73.53M61.7M149.38M41.39M34.2M
Other Long-Term Investments 73.53M61.7M149.38M41.39M34.2M
Long-Term Note Receivable -----
Intangible Assets -----
Net Goodwill -----
Net Other Intangibles -----
Other Assets 319,000490,0006.61M1.16M962,000
Tangible Other Assets 319,000490,000764,0001.16M962,000
Total Assets 271.07M486.72M661.98M553.23M1.6B

Liabilities & Shareholders' Equity

20162017201820192020 5-year trend
ST Debt & Current Portion LT Debt ---3.67M4.69M
Short Term Debt ---3.67M4.69M
Current Portion of Long Term Debt -----
Accounts Payable 1.96M2.72M1.89M2.59M1.07M
Income Tax Payable -----
Other Current Liabilities 7.14M11.45M30.9M39.09M65.94M
Dividends Payable -----
Accrued Payroll 2.59M5.17M9.95M8.74M20.5M
Miscellaneous Current Liabilities 4.55M6.28M20.94M30.35M45.44M
Total Current Liabilities 9.11M14.16M32.79M45.34M71.7M
Long-Term Debt ---68.87M64.18M
Long-Term Debt excl. Capitalized Leases -----
Non-Convertible Debt -----
Convertible Debt -----
Capitalized Lease Obligations -----
Provision for Risks & Charges -----
Deferred Taxes -----
Deferred Taxes - Credit -----
Deferred Taxes - Debit -----
Other Liabilities 7.44M6.76M82.35M44.13M317.88M
Other Liabilities (excl. Deferred Income) 7.44M6.76M25M379,000701,000
Deferred Income --57.35M43.75M317.17M
Total Liabilities 16.55M20.93M115.14M158.34M453.75M
Non-Equity Reserves -----
Preferred Stock (Carrying Value) 348.67M----
Redeemable Preferred Stock 348.67M----
Non-Redeemable Preferred Stock -----
Common Equity (Total) (94.15M)465.8M546.85M394.89M1.15B
Common Stock Par/Carry Value 344,0001.2M1.27M1.29M1.53M
Retained Earnings (103.51M)(191.7M)(227.94M)(425.55M)(354.42M)
ESOP Debt Guarantee -----
Cumulative Translation Adjustment/Unrealized For. Exch. Gain -----
Unrealized Gain/Loss Marketable Securities -(368,000)(649,000)350,000(245,000)
Revaluation Reserves -----
Treasury Stock -----
Total Shareholders' Equity 254.52M465.8M546.85M394.89M1.15B
Accumulated Minority Interest -----
Total Equity 254.52M465.8M546.85M394.89M1.15B
Liabilities & Shareholders' Equity 271.07M486.72M661.98M553.23M1.6B
Link to MarketWatch's Slice.